PRDM9 and hepatocellular carcinoma: In the screening pipeline, we used public RNA-seq data from 50 normal livers and 371 HCC tissues derived from the TCGA portal and analyzed the expression levels with an in silico panel of histone methyltransferases/demethylases (Figure 1).